Drug Delivery Across Blood-Brain Barrier Market By Delivery Method (Invasive Techniques {Intracerebroventricular Delivery, Intrathecal Delivery, Convection-Enhanced Delivery}, Non-Invasive Techniques {Receptor-Mediated Transport, Carrier-Mediated Transport, Adsorptive-Mediated Transcytosis, Focused Ultrasound Assisted Delivery, Exosome-Based Delivery}), By Drug Type (Small Molecules, Biologics {Monoclonal Antibodies, Peptides & Proteins, RNA-Based Drugs}, Gene Therapy Agents, Stem Cell-Based Therapies), By Carrier System (Liposomes, Polymeric Nanoparticles, Dendrimers, Viral Vectors, Exosomes & Extracellular Vesicles), By Application (Alzheimer’s Disease, Parkinson’s Disease, Glioblastoma, Epilepsy, Multiple Sclerosis, Neuroinfections, Psychiatric Disorders, Rare Genetic CNS Disorders, Other), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Research Supply Chains), and By End-user (Hospitals, Neurosurgery Centers, Specialty Clinics, Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Apr 2025 | Report ID: MI2549 | 215 Pages
Report Coverage:
By Delivery Method
- Invasive Techniques
- Intracerebroventricular (ICV) Delivery
- Intrathecal Delivery
- Convection-Enhanced Delivery (CED)
- Non-Invasive Techniques
- Receptor-Mediated Transport (RMT)
- Carrier-Mediated Transport (CMT)
- Adsorptive-Mediated Transcytosis (AMT)
- Focused Ultrasound (FUS)-Assisted Delivery
- Exosome-Based Delivery
By Drug Type
- Small Molecules
- Biologics
- Monoclonal Antibodies
- Peptides & Proteins
- RNA-Based Drugs
- Gene Therapy Agents
- Stem Cell-Based Therapies
By Carrier System
- Liposomes
- Polymeric Nanoparticles
- Dendrimers
- Viral Vectors
- Exosomes & Extracellular Vesicles
By Application
- Alzheimer’s Disease
- Parkinson’s Disease
- Glioblastoma
- Epilepsy
- Multiple Sclerosis
- Neuroinfections
- Psychiatric Disorders
- Rare Genetic CNS Disorders
- Other
By Distribution Channel
- Hospital Pharmacies
- Specialty Pharmacies
- Research Supply Chains
By End-User
- Hospitals
- Neurosurgery Centers
- Specialty Clinics
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Institutions
By Region
North America
- The U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East & Africa
List of Companies:
- F. Hoffmann-La Roche Ltd
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Novartis AG
- Merck & Co., Inc.
- Sanofi S.A.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Amgen Inc.
- GlaxoSmithKline plc
- BioArctic AB
- Takeda Pharmaceutical Company Limited
- Bayer AG
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.